221 related articles for article (PubMed ID: 16441673)
1. Complementary and alternative medicine use in patients with head and neck cancers in Europe.
Molassiotis A; Ozden G; Platin N; Scott JA; Pud D; Fernandez-Ortega P; Milovics L; Panteli V; Gudmundsdottir G; Browall M; Madsen E; Patiraki E; Kearney N
Eur J Cancer Care (Engl); 2006 Mar; 15(1):19-24. PubMed ID: 16441673
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine use in patients with haematological malignancies in Europe.
Molassiotis A; Margulies A; Fernandez-Ortega P; Pud D; Panteli V; Bruyns I; Scott JA; Gudmundsdottir G; Browall M; Madsen E; Ozden G; Magri M; Selvekerova S; Platin N; Kearney N; Patiraki E
Complement Ther Clin Pract; 2005 May; 11(2):105-10. PubMed ID: 15955292
[TBL] [Abstract][Full Text] [Related]
3. Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N
Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine use in lung cancer patients in eight European countries.
Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
[TBL] [Abstract][Full Text] [Related]
5. Use of complementary and alternative medicine among cancer patients in Israel.
Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
[TBL] [Abstract][Full Text] [Related]
6. Use of complementary and alternative medicine in head and neck cancer patients.
Lim CM; Ng A; Loh KS
J Laryngol Otol; 2010 May; 124(5):529-32. PubMed ID: 20163747
[TBL] [Abstract][Full Text] [Related]
7. Use of complementary medicine by adult patients participating in cancer clinical trials.
Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
[TBL] [Abstract][Full Text] [Related]
8. Complementary and alternative medicine use in patients presenting to a head and neck oncology clinic.
Vyas T; Hart RD; Trites JR; Philips TJ; Archibald KE; Phillips JE; Taylor SM
Head Neck; 2010 Jun; 32(6):793-9. PubMed ID: 19890909
[TBL] [Abstract][Full Text] [Related]
9. Treatment delay associated with alternative medicine use among veterans with head and neck cancer.
Davis GE; Bryson CL; Yueh B; McDonell MB; Micek MA; Fihn SD
Head Neck; 2006 Oct; 28(10):926-31. PubMed ID: 16755583
[TBL] [Abstract][Full Text] [Related]
10. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine use in the thyroid patients of a head and neck practice.
Brake MK; Bartlett C; Hart RD; Trites JR; Taylor SM
Otolaryngol Head Neck Surg; 2011 Aug; 145(2):208-12. PubMed ID: 21521893
[TBL] [Abstract][Full Text] [Related]
12. Frequency of use of complementary and alternative medicine in women with breast cancer.
Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
[TBL] [Abstract][Full Text] [Related]
13. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
Ezeome ER; Anarado AN
BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
Can G; Erol O; Aydiner A; Topuz E
Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
[TBL] [Abstract][Full Text] [Related]
15. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
Shumay DM; Maskarinec G; Kakai H; Gotay CC;
J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
[TBL] [Abstract][Full Text] [Related]
16. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
17. Use of alternative and complementary therapies in children with cancer.
Martel D; Bussières JF; Théorêt Y; Lebel D; Kish S; Moghrabi A; Laurier C
Pediatr Blood Cancer; 2005 Jun; 44(7):660-8. PubMed ID: 15714446
[TBL] [Abstract][Full Text] [Related]
18. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
[TBL] [Abstract][Full Text] [Related]
19. Use of complementary and alternative medicine in patients with cancer: a UK survey.
Scott JA; Kearney N; Hummerston S; Molassiotis A
Eur J Oncol Nurs; 2005 Jun; 9(2):131-7. PubMed ID: 15944106
[TBL] [Abstract][Full Text] [Related]
20. Complementary and alternative medications consumed by renal patients in southern Germany.
Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
